Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases

  1. Jayoung Kim2,3⇑
  1. 1Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, Korea
  2. 2Departments of Surgery and Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA
  3. 3Department of Medicine, University of California, Los Angeles, California, USA
  1. Correspondence should be addressed to M H Choi or J Kim; Email: mh_choi{at}kist.re.kr or Jayoung.Kim{at}cshs.org
  1. Figure 1

    Overview of cholesterol and steroid hormone pathways.

  2. Figure 2

    Our metabolomic profile showing the distinct patterns between prostate cancer and healthy controls.

  3. Figure 3

    High cholesterol, high sex steroids and hair loss were observed in mice with chronic high-cholesterol diet. Line within the value represents the median.

  4. Figure 4

    Metabolic ratios of hair androgens in patients with prostate cancer and male pattern baldness compared with healthy control subjects. Line within the value represents the median.

  5. Figure 5

    The clinically applicable hair metabolomic approaches to monitor cholesterol and steroid hormone levels in urological diseases.

| Table of Contents
OPEN ACCESS ARTICLE